Condensed Consolidated Statements of Operations - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Total revenues	$ 24,560	$ 22,749	$ 46,777	$ 42,245
Total costs and expenses	(22,146)	(20,314)	(41,817)	(37,393)
Gross profit	2,414	2,435	4,960	4,852
Income from operating investments, net	24	25	14	28
General and administrative expense	(1,428)	(1,793)	(2,625)	(2,905)
Research and development expense, net	(921)	(910)	(1,824)	(1,754)
Gain on dispositions, net	67	67	79	64
Earnings/(loss) from operations	156	(176)	604	285
Other income, net	79	325	273	648
Interest and debt expense	(600)	(710)	(1,216)	(1,418)
Loss before income taxes	(365)	(561)	(339)	(485)
Income tax expense	(63)	(51)	(96)	(158)
Net loss	(428)	(612)	(435)	(643)
Less: Net earnings/(loss) attributable to noncontrolling interest	16	(1)	13	5
Net loss attributable to Boeing shareholders	(444)	(611)	(448)	(648)
Less: Mandatory convertible preferred stock dividends accumulated during the period	86	86	172	172
Net loss attributable to Boeing common shareholders	(530)	(697)	(620)	(820)
Net loss attributable to Boeing common shareholders	$ (530)	$ (697)	$ (620)	$ (820)
Basic loss per share (in dollars per share)	$ (0.67)	$ (0.92)	$ (0.79)	$ (1.09)
Diluted loss per share (in dollars per share)	$ (0.67)	$ (0.92)	$ (0.79)	$ (1.09)
Product
Total revenues	$ 21,366	$ 19,122	$ 40,364	$ 35,269
Cost of products and services	(19,487)	(17,406)	(36,518)	(31,785)
Service
Total revenues	3,194	3,627	6,413	6,976
Cost of products and services	$ (2,659)	$ (2,908)	$ (5,299)	$ (5,608)

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows – operating activities:
Net (loss)/earnings	$ (435)	$ (643)
Non-cash items –
Share-based plans expense	264	254
Treasury shares issued for 401(k) contributions	855	793
Depreciation and amortization	1,169	926
Investment/asset impairment charges, net	18	30
Gain on dispositions, net	(79)	(64)
Other charges and credits, net	149	162
Changes in assets and liabilities –
Accounts receivable	(553)	(683)
Unbilled receivables	(504)	(908)
Advances and progress billings	4,660	(616)
Inventories	(3,859)	(374)
Other current assets	(642)	265
Accounts payable	1,381	(46)
Accrued liabilities	(1,070)	(248)
Income taxes receivable, payable and deferred	(20)	(3)
Other long-term liabilities	(92)	(212)
Pension and other postretirement plans	(55)	(292)
Financing receivables and operating lease equipment, net	(137)	185
Other	135	85
Net cash provided/(used) by operating activities	1,185	(1,389)
Cash flows – investing activities:
Payments to acquire property, plant and equipment	(2,008)	(1,101)
Proceeds from disposals of property, plant and equipment	3	4
Proceeds from dispositions		35
Contributions to investments	(19,444)	(21,581)
Proceeds from investments	25,090	18,847
Supplier notes receivable	(11)	(150)
Other	(1)
Net cash provided/(used) by investing activities	3,629	(3,946)
Cash flows – financing activities:
New borrowings	35	98
Debt repayments	(8,376)	(677)
Employee taxes on certain share-based payment arrangements	(32)	(18)
Dividends paid on mandatory convertible preferred stock	(172)	(158)
Other	32	30
Net cash used by financing activities	(8,513)	(725)
Effect of exchange rate changes on cash and cash equivalents	2	34
Net decrease in cash & cash equivalents, including restricted	(3,697)	(6,026)
Cash & cash equivalents, including restricted, at beginning of year	11,663	13,822
Cash & cash equivalents, including restricted, at end of period	7,966	7,796
Less restricted cash & cash equivalents, included in Investments	727	709
Cash and cash equivalents at end of period	$ 7,239	$ 7,087

Condensed Consolidated Statements of Financial Position - USD ($) $ in Millions	Jun. 30, 2026	Dec. 31, 2025
Assets
Cash and cash equivalents	$ 7,239	$ 10,921
Short-term and other investments	12,783	18,479
Accounts receivable, net	3,515	2,921
Unbilled receivables, net	9,660	9,158
Inventories	88,388	84,679
Other current assets, net	3,045	2,301
Total current assets	124,630	128,459
Financing receivables and operating lease equipment, net	365	241
Property, plant and equipment, net of accumulated depreciation of $24,318 and $23,613	16,321	15,361
Goodwill	17,554	17,275
Acquired intangible assets, net	1,531	1,567
Deferred income taxes	152	107
Investments	1,117	1,048
Other assets, net of accumulated amortization of $1,138 and $1,014	4,200	4,177
Total assets	165,870	168,235
Liabilities and equity
Accounts payable	14,346	13,109
Accrued liabilities	26,593	27,141
Advances and progress billings	64,059	59,404
Short-term debt and current portion of long-term debt	4,565	8,461
Total current liabilities	109,563	108,115
Deferred income taxes	260	216
Accrued retiree health care	2,027	2,091
Accrued pension plan liability, net	4,108	4,287
Other long-term liabilities	2,462	2,432
Long-term debt	41,335	45,637
Total liabilities	159,755	162,778
Shareholders’ equity:
Common stock, par value $5.00 – 1,200,000,000 shares authorized; 1,012,261,159 shares issued	5,061	5,061
Additional paid-in capital	21,949	21,441
Treasury stock, at cost – 222,468,625 and 227,562,887 shares	(27,416)	(28,029)
Retained earnings	16,632	17,252
Accumulated other comprehensive loss	(10,132)	(10,277)
Total shareholders' equity	6,100	5,454
Noncontrolling interests	15	3
Total equity	6,115	5,457
Total liabilities and equity	165,870	168,235
Mandatory convertible preferred stock
Shareholders’ equity:
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 – 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750	$ 6	$ 6